Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease

Completed · Phase 1/Phase 2

Conditions studied: Liver Cancer

In brief

The goal of this clinical research study is to test the accuracy of magnetic resonance elastogram (MRE) and 2-point dixon magnetic resonance imaging (2PD MRI) using new computer software (called "phase correction algorithm") in patients who might have liver disease.

Key facts

Study ID

NCT00543777

Run by

M.D. Anderson Cancer Center

People needed

44

Starts

2007-09-01

Expected to finish

2020-01-13

Last updated by the study team

2021-04-13

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Group 1. Non-oncologic patients from VAMC in Houston:
• Biopsy proven or clinically suspected advanced parenchymal liver disease
• Core biopsies obtained within 1-month of MRI/MRE
• No treatment affecting the status of liver between MRI/MRE and post-imaging biopsy
• Signed consent
• Group 2. Oncologic patients at MDACC:
• Clinically or radiographically suspected liver damage, hepatic steatosis, hepatitis, hepatic fibrosis or cirrhosis
• Surgical or core biopsy scheduled within 4 weeks of MRI/MRE
• Signed consent

You may not qualify if…

• Claustrophobia
• Contraindications for MRI
• Unable to hold a breath
• Ascites or other clinical or radiographical signs of portal hypertension

Where it is running

• University of Texas MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.